<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01501045</url>
  </required_header>
  <id_info>
    <org_study_id>TMS-001</org_study_id>
    <nct_id>NCT01501045</nct_id>
  </id_info>
  <brief_title>Effect of Transmagnetic Stimulation on Conditioned Pain Modulation (CPM)</brief_title>
  <official_title>The Effect of Transmagnetic Stimulation on Descending Pain Modulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      While some indications of the neural circuits involved in the Conditioned Pain Modulation&#xD;
      (CPM) process are now available, there is still need to clarify what parts of the brain are&#xD;
      essential for this process, whether the spino-brainstem loop is largely sufficient to explain&#xD;
      CPM or whether other cerebral and spinal regions such as frontal, somatosensory and other&#xD;
      cortical regions contribute substantially. Whereas mere observation of correlation between&#xD;
      these circuits while activated by brain imaging is still of considerable interest, direct&#xD;
      experimental manipulations by repetitive transcranial magnetic stimulation (rTMS) could even&#xD;
      establish insights into causal relationships.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      rTMS of different intensities, frequencies and location will be applied during CPM to&#xD;
      evaluate the central mechanisms of pain modulation, their location and role in pain reduction&#xD;
      through enhancement or suppression of activity in the relevant brain regions. In other words,&#xD;
      cortical regions that may be implicated in CPM will be determined by augmenting or&#xD;
      interrupting their activity via rTMSapplied to the areas under investigation. The regions&#xD;
      will be the pain network sites, which are assumed to control the top-down influence on CPM&#xD;
      and are superficial enough to be stimulated by the magnetic coil. These include primarily&#xD;
      DLPFC (dorsolateral prefrontal cortex) and OFC (orbitofrontal cortex), with possible later&#xD;
      addition of other relevant sites such as ACC (anterior cortex cinguli), insula and&#xD;
      somatosensory cortices, etc. Since rTMS may be administered in a manner that either reduces&#xD;
      or enhances the excitability of the stimulated cortical region, it should be possible to&#xD;
      clarify the inhibitory or excitatory role of these regions in the CPM process. In summary,&#xD;
      the planned studies should allow for identifying the cortical regions of the descending pain&#xD;
      system, which are critical as starting points for the top-down modulation of CPM.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2011</start_date>
  <completion_date type="Actual">November 6, 2017</completion_date>
  <primary_completion_date type="Actual">November 6, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain scores as measured by pain numerical scale (NPS)</measure>
    <time_frame>1 week</time_frame>
    <description>TMS directed to pain inhibitory cortical areas will evoke pain reduction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Amplitude of pain-evoked potentials</measure>
    <time_frame>1 week</time_frame>
    <description>Change in pain evoked potentials will be assessed before and after the TMS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>conditioned pain modulation (CPM)</measure>
    <time_frame>1 week</time_frame>
    <description>Change in the efficiency of CPM will be assessed in response to TMS</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">94</enrollment>
  <condition>Headache</condition>
  <condition>Migraine</condition>
  <arm_group>
    <arm_group_label>healthy subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>healthy subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pain patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Migraine and muscle headache patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TMS system MagPro x100, Tonica Elektronik A/S, Denmark</intervention_name>
    <description>repeated TMS (rTMS)</description>
    <arm_group_label>healthy subjects</arm_group_label>
    <other_name>Transcranial Magnetic Stimulator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TMS system MagPro x100, Tonica Elektronik A/S, Denmark</intervention_name>
    <description>repeated TMS</description>
    <arm_group_label>pain patients</arm_group_label>
    <other_name>Transcranial Magnetic Stimulator</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18-70&#xD;
&#xD;
          -  males and females&#xD;
&#xD;
          -  right handed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  metal in brain/skull&#xD;
&#xD;
          -  cardiac pacemaker&#xD;
&#xD;
          -  cohlear implants&#xD;
&#xD;
          -  history of head trauma&#xD;
&#xD;
          -  history of epilepsy or seizures&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Yarnitsky, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The lab of clinical neurophysiology, the faculty of medicine, Technion and Rambam Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>December 12, 2011</study_first_submitted>
  <study_first_submitted_qc>December 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2011</study_first_posted>
  <last_update_submitted>March 26, 2019</last_update_submitted>
  <last_update_submitted_qc>March 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>d_yarnitsky</investigator_full_name>
    <investigator_title>head of Neurology Department</investigator_title>
  </responsible_party>
  <keyword>TMS</keyword>
  <keyword>CPM</keyword>
  <keyword>headache</keyword>
  <keyword>migraine</keyword>
  <keyword>EEG</keyword>
  <keyword>psychophysics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

